HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Multilab Indústria e Comércio de Produtos Farma

http://www.multilab.com.br

Latest From Multilab Indústria e Comércio de Produtos Farma

Deal Watch Asia Focus: Pfenex Licenses Asian Rights To Forteo Copy To NT Pharma Group

Otsuka obtains Japanese rights to two cancer gene therapy candidates from Takara. GlaxoSmithKline extends its protein degradation collaboration with Kymera.

Commercial Business Strategies

Takeda Sheds Multilab In Brazil As Strategic Priorities Shift

Takeda is selling its Multilab operation in Brazil, in a reversal of a deal to buy the mid-sized company around six years ago to bolster its position and generic/OTC portfolios in the country.

Brazil Commercial

Takeda Uses Fine Tooth Comb To Find Inefficiencies After Poor Results

The belt-tightening has already hit Takeda’s oncology arm, leading to the exit of Deborah Dunsire, chief executive officer at Millennium: The Takeda Oncology Co.

Takeda Uses Fine Tooth Comb To Find Inefficiencies After Poor Results

The belt-tightening has already hit Takeda’s oncology arm, leading to the exit of Deborah Dunsire, chief executive officer at Millennium: The Takeda Oncology Co.

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
UsernamePublicRestriction

Register